Skip to main content
. Author manuscript; available in PMC: 2015 Mar 30.
Published in final edited form as: Appl Physiol Nutr Metab. 2013 Sep 11;39(2):238–247. doi: 10.1139/apnm-2013-0274

Figure 1.

Figure 1

Left ventricle and atria masses and LV ejection fraction (LVEF) after 14 weeks of treatment in Protocol 1. *P < 0.05 compared with respective sham. The group sizes were 15 and 19 for sham and heart failure, respectively, with 18% protein, and 11 and 16 for sham and heart failure, respectively, with 30% protein.